Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): Phase 3 study in Locally Advanced Pancreatic Carcinoma (LAPC) (230 participants)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA): Phase 3 study in Locally Advanced Pancreatic Carcinoma (LAPC) (230 participants). Its enrollment of 230 is above the median of 80 (79th percentile). Dated 26 days ago, it is in the active follow-up window. Score 55/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 230 · 79th percentile of 8,879 ClinicalTrialStartPulse records · 2.9x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Sponsor type | Academic and hospital |
| Study | Surgery Versus Stereotactic Ablative Radiotherapy for Patients With Locally Advanced Pancreatic Cancer With Favourable Biological Response Following Induction Chemotherapy |
| NCT ID | NCT07867873 |
| Phase | Phase 3 |
| Status | not yet recruiting |
| Conditions | Locally Advanced Pancreatic Carcinoma (LAPC) |
| Intervention types | procedure, radiation |
| Target enrollment | 230 |
| Posted | 2026-10-09 |
| Planned start | 2026-10-01 |
| Event | Newly registered study |
| Event date | 2026-10-09 |
| enrollment percentile | 79th of 8,879 (median 80, 2.9x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-09
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)'s enrollment: 79th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
55 / 100 Score
- Phase 3: multi-site, larger budget.
- 230 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)?
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) registered a Phase 3 study (NCT07867873) in Locally Advanced Pancreatic Carcinoma (LAPC) targeting 230 participants, posted 2026-10-09.
How does Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) compare to other ClinicalTrialStartPulse records?
Its enrollment of 230 sits in the upper half (79th percentile) of 8,879 records; the median is 80. It is 26 days old, still within a typical 45-day follow-up window.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | NONUS | 230 | 79th | 2026-10-09 |
| Genmab | US | 191 | 75th | 2026-11-03 |
| AstraZeneca | US | 181 | 74th | 2026-11-03 |
| Janssen-Cilag Ltd. | US | 288 | 82nd | 2026-11-03 |
Related records
ClinicalTrialStartPulse: Phase 3 ClinicalTrialStartPulse: Outside the US only
How to monitor Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and peer phase 3 records
Get new ClinicalTrialStartPulse records like Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.